Showing 1 - 8 results of 8 for search 'Serenella M. Pupa', query time: 0.04s Refine Results
  1. 1
    Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

    Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness by Lorenzo Castagnoli, Elda Tagliabue, Serenella M. Pupa

    Published 2020-11-01
    Get full text
    Article
  2. 2
    The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?

    The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers? by Lorenzo Castagnoli, Michael Ladomery, Elda Tagliabue, Serenella M. Pupa

    Published 2019-06-01
    Get full text
    Article
  3. 3
    HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness

    HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness by Serenella M. Pupa, Francesca Ligorio, Valeria Cancila, Alma Franceschini, Claudio Tripodo, Claudio Vernieri, Lorenzo Castagnoli

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure

    Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure by Lorenzo Castagnoli, Francesca De Santis, Tatiana Volpari, Claudio Vernieri, Elda Tagliabue, Massimo Di Di Nicola, Serenella M Pupa

    Published 2020-02-01
    Get full text
    Article
  5. 5
    The Emerging Role of the Microbiota in Breast Cancer Progression

    The Emerging Role of the Microbiota in Breast Cancer Progression by Giancarla Bernardo, Valentino Le Noci, Martina Di Modica, Elena Montanari, Tiziana Triulzi, Serenella M. Pupa, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini

    Published 2023-07-01
    Get full text
    Article
  6. 6
    Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients

    Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients by Francesca Ligorio, Luca Zambelli, Achille Bottiglieri, Lorenzo Castagnoli, Emma Zattarin, Riccardo Lobefaro, Arianna Ottini, Andrea Vingiani, Serenella M. Pupa, Giulia V. Bianchi, Giuseppe Capri, Giancarlo Pruneri, Filippo de Braud, Claudio Vernieri

    Published 2021-04-01
    Get full text
    Article
  7. 7
    Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

    Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD). by Federico Gabrielli, Roberto Salvi, Chiara Garulli, Cristina Kalogris, Serena Arima, Luca Tardella, Paolo Monaci, Serenella M Pupa, Elda Tagliabue, Maura Montani, Elena Quaglino, Lorenzo Stramucci, Claudia Curcio, Cristina Marchini, Augusto Amici

    Published 2013-01-01
    Get full text
    Article
  8. 8
    The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

    The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse. by Cristina Marchini, Federico Gabrielli, Manuela Iezzi, Santa Zenobi, Maura Montani, Lucia Pietrella, Cristina Kalogris, Anna Rossini, Valentina Ciravolo, Lorenzo Castagnoli, Elda Tagliabue, Serenella M Pupa, Piero Musiani, Paolo Monaci, Sylvie Menard, Augusto Amici

    Published 2011-01-01
    Get full text
    Article

Search Tools: